A surprising event occurred in the Oval Office when Gordon Findlay, a Novo Nordisk executive, suddenly collapsed while standing next to President Donald Trump during a live speech addressing drug prices. The press was quickly escorted out as officials rushed to provide aid.
The White House confirmed that Findlay had fainted but reassured the public that he was “OK.”
"Findlay had fainted and was 'OK,'" the White House stated.
This incident has reignited discussions about the ongoing healthcare challenges in the United States, particularly the rising costs of medications.
The unexpected collapse of a pharma executive during a high-profile speech highlights the intense pressures surrounding America's drug pricing crisis.